Adolescent Medicine Trials Network for HIV/AIDS Interve*
艾滋病毒/艾滋病干预青少年医学试验网络*
基本信息
- 批准号:7901671
- 负责人:
- 金额:$ 66.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-16 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAddressAdherenceAdolescentAdolescent MedicineAdolescent Medicine Trials NetworkAreaBehavioralCaringCase ManagementCellular PhoneClinical TrialsCommunitiesCommunity TrialCompassionCountyData QualityDevelopmentGeographic LocationsHIVHealthHealth Services ResearchHealth educationHealthcareHospitalsInterventionInterviewLos AngelesLoveMedicalMedical EducationMental HealthMissionModelingPopulationPregnancyPreventionPreventiveProcessProductionProtocols documentationPublic HealthResearchResearch InfrastructureResearch TrainingResourcesRiskServicesSiteSite VisitSurveysTherapeuticTherapy Clinical TrialsUnited StatesYouthbasechild well beingclinical careexperienceindexinginnovationmultidisciplinaryperformance siteplanetary Atmosphereprogramsresponsesubstance abuse treatmenttertiary preventionviolence prevention
项目摘要
The mission of Childrens Hospital Los Angeles (CHLA) is "to advance the health and well-being of children
and adolescents by integrating medical care, preventive services, medical education, and research in
response to the needs of our community and in an atmosphere of love, compassion, and respect for people."
Since the early 1980's, the Division of Adolescent Medicine at CHLA has focused on reducing risks for
young people through innovative models of service, research and training established in partnership with the
community. Through these programs, the Division provides health care, mental health, case management,
health education, and substance abuse treatment services to over 9000 youth annually, and is involved in
community-level interventions for pregnancy, HIV, and violence prevention.
Since the inception of the Adolescent Trials Network (ATM), CHLA has established itself as a
productive Adolescent Medicine Trials Unit (ATU), contributing to the primary mission of the ATUs in the
recruitment and retention of subjects in clinical trials and production of high quality data. In the area of
behavioral trials, CHLA has far greater participation and recruitment than any other ATM site. For community
prevention trials (Connect to Protect¿), CHLA is one of the first three (of fifteen) sites to complete the index
interviews and begin the brief venue based surveys. As for therapeutic trials, CHLA has consistently been in
the top third for recruitment. The quality of our site management is reflected in consistently positive reviews
at our semi-annual site visits.
The Los Angeles ATU has not only established itself as a productive ATU, but has contributed to the
ATM through active involvement in committees and the development of new behavioral protocols. The site
PI has been the ATU chair for all five years of this project and served on the Executive and Site performance
committees. In addition, CHLA is one of the few ATU sites to have initiated an ATN protocol (ATN 039).
CHLA is currently in the process of developing yet another original protocol involving the use of cell phones
as reminders to address non-adherence.
The following application documents that Childrens Hospital Los Angeles (CHLA), Division of
Adolescent Medicine has the experience, expertise and infrastructure necessary to participate as a site in
the ATN. Our core staffing plans will allow us to continue effective recruitment and retention into
therapeutic, behavioral and community trials. In addition our experienced staff will continue to be active in
the development of new protocols and thus allow us to continue to contribute to the ATN scientific agenda.
The ATN research agenda is of particular relevance to public health, as it will significantly contribute to our
understanding of HIV in adolescents.
洛杉矶儿童医院(CHLA)的使命是“促进儿童的健康和福祉
通过整合医疗保健、预防服务、医学教育和研究
在爱、同情和尊重他人的氛围中,回应我们社区的需求。
自20世纪80年代初以来,中华医学会青少年医学部一直专注于降低青少年感染风险
通过与联合国儿童基金会合作建立的创新服务、研究和培训模式,帮助青年
社区。通过这些方案,该司提供保健、精神健康、病例管理、
每年向9000多名青少年提供健康教育和药物滥用治疗服务,并参与
社区一级的怀孕、艾滋病毒和暴力预防干预措施。
自青少年试验网络(ATM)成立以来,CHLA已成为
生产青少年医学试验股(ATU),为ATU在全球的主要任务做出贡献
在临床试验中招募和保留受试者,并产生高质量的数据。在……方面
行为试验,CHLA比任何其他ATM网站都有更多的参与和招募。对于社区而言
预防试验(Connect To Protected),CHLA是(15个网站中)首批完成索引的三个网站之一
访谈,并开始简短的基于地点的调查。至于治疗试验,CHLA一直在
招聘人数排在前三分之一。我们网站管理的质量反映在持续的积极评价中
在我们每半年一次的现场考察中。
洛杉矶ATU不仅确立了自己作为一个富有成效的ATU的地位,而且还为
ATM通过积极参与委员会和开发新的行为规范。该网站
在本项目的所有五年中,Pi一直担任ATU主席,并在执行和现场表演中担任职务
委员会。此外,CHLA是少数几个启动ATN协议(ATN 039)的ATU站点之一。
CHLA目前正在制定另一项涉及使用手机的原始协议
作为对解决不遵守规定问题的提醒。
以下申请文件由洛杉矶儿童医院(CHLA)分部
青少年医学具有作为网站参与所需的经验、专业知识和基础设施
ATN。我们的核心人员计划将使我们能够继续有效地招聘和留住
治疗、行为和社区试验。此外,我们经验丰富的员工将继续积极参与
新议定书的制定,从而使我们能够继续为ATN科学议程作出贡献。
ATN研究议程与公共卫生特别相关,因为它将对我们的
青少年对艾滋病毒的了解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARVIN E BELZER其他文献
MARVIN E BELZER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARVIN E BELZER', 18)}}的其他基金
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10709604 - 财政年份:2022
- 资助金额:
$ 66.62万 - 项目类别:
Children's Hospital Los Angeles Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
洛杉矶儿童医院站点联盟 - HIV/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
- 批准号:
10599558 - 财政年份:2022
- 资助金额:
$ 66.62万 - 项目类别:
Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in Young Transgender Women
LifeSkills Mobile 数字化、有限互动功效试验可降低年轻跨性别女性的艾滋病毒发病率
- 批准号:
10598468 - 财政年份:2021
- 资助金额:
$ 66.62万 - 项目类别:
Digital, Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in Young Transgender Women
LifeSkills Mobile 数字化、有限互动功效试验可降低年轻跨性别女性的艾滋病毒发病率
- 批准号:
10369005 - 财政年份:2021
- 资助金额:
$ 66.62万 - 项目类别:
Youth Services Navigation Intervention for HIV+ adolescents and young adults being released from incarceration: A randomized control trial
针对从监狱释放的艾滋病毒青少年和年轻人的青年服务导航干预:一项随机对照试验
- 批准号:
9890791 - 财政年份:2017
- 资助金额:
$ 66.62万 - 项目类别:
Youth Services Navigation Intervention for HIV+ adolescents and young adults being released from incarceration: A randomized control trial
针对出狱的艾滋病毒青少年和年轻人的青年服务导航干预:一项随机对照试验
- 批准号:
9540937 - 财政年份:2017
- 资助金额:
$ 66.62万 - 项目类别:
PK STUDY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING TENFOVIR AND ATAZANIVIR
含替福韦和阿扎尼韦的抗逆转录病毒治疗方案的药代动力学研究
- 批准号:
7716626 - 财政年份:2008
- 资助金额:
$ 66.62万 - 项目类别:
PK STUDY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING TENFOVIR AND ATAZANIVIR
含替福韦和阿扎尼韦的抗逆转录病毒治疗方案的药代动力学研究
- 批准号:
7603853 - 财政年份:2006
- 资助金额:
$ 66.62万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interve*
艾滋病毒/艾滋病干预青少年医学试验网络*
- 批准号:
7195770 - 财政年份:2001
- 资助金额:
$ 66.62万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interve*
艾滋病毒/艾滋病干预青少年医学试验网络*
- 批准号:
7414388 - 财政年份:2001
- 资助金额:
$ 66.62万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 66.62万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 66.62万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 66.62万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 66.62万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 66.62万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 66.62万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 66.62万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 66.62万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 66.62万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 66.62万 - 项目类别:














{{item.name}}会员




